N/A
Completed N=40
Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically Treated
Head and Neck Cancer · Synbiotics · Nutrition Therapy
Source: ClinicalTrials.gov NCT02654652 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcomePrimary: Serum DAO Enzyme Concentration — 3; 2.5 ng/mL
Summary
The purpose of this study is to determine whether the symbiotic use in patients with head and neck cancer impact on intestinal function after surgical treatment.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum DAO Enzyme Concentration |
3; 2.5 | — |
| SECONDARY Infection Rate |
11; 7 | — |
Eligibility Criteria
Inclusion Criteria
- head and neck cancer with primary surgical treatment, enteral nutrition by enteral tube.
Exclusion Criteria
- three months antibiotic use earlier the surgery, recently radiotherapy or quimiotherapy, inflammatory bowel disease.
Data sourced from ClinicalTrials.gov (NCT02654652). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.